Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus genotypes in Australia

R McCaw1, L Moaven, S A Locarnini

  • 1Victorian Infectious Diseases Reference Laboratory, Fairfield, Melbourne, Australia.

Journal of Viral Hepatitis
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.

Epidemiology and infection·2016
Same author

Vidal LL, et al. NS3 protease polymorphisms and genetic barrier to drug resistance of distinct HCV genotypes from worldwide treatment-naive subjects. JVH, 2016, 23(11): 840-849.

Journal of viral hepatitis·2016
Same author

The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.

Alimentary pharmacology & therapeutics·2015
Same author

A novel hepatitis B virus S gene insertion associated with reduced humoral immunity and diagnostic escape.

Internal medicine journal·2014
Same author

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.

Journal of virology·2014
Same author

Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare.

Alimentary pharmacology & therapeutics·2014

Australian hepatitis C virus (HCV) genotype distribution shows a predominance of genotype 1 (55%) and genotype 3 (38%), with genotype 3a being the most common subtype. Genotype 1b was more frequent in transfusion-acquired cases.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) infection remains a significant global health concern.
  • Understanding regional genotype distribution is crucial for effective treatment and prevention strategies.
  • Previous studies indicate global variations in HCV genotype prevalence.

Purpose of the Study:

  • To determine the relative distribution of HCV genotypes in a cohort of 500 Australian isolates.
  • To investigate associations between HCV genotypes and risk factors such as mode of acquisition and patient age.
  • To compare Australian HCV genotype prevalence with that typically found in developed countries.

Main Methods:

  • HCV genotyping was performed on 500 isolates using a commercial reverse phase hybridization assay.

Related Experiment Videos

  • The 5' untranslated region of the HCV genome was amplified via polymerase chain reaction (PCR) prior to hybridization.
  • Statistical analyses were employed to compare genotype frequencies across different risk groups and age demographics.

    • Main Results:

    • Australian HCV isolates were predominantly genotype 1 (55%) and genotype 3 (38%), with genotype 2 accounting for only 7%.
    • Genotype 3a was identified as the most common subtype.
    • A significantly higher incidence of genotype 1b was observed in transfusion-acquired hepatitis C cases compared to injecting drug users (P < 0.03).
    • Genotype 3a was more prevalent in the 21-40-year age group than in the 41-60-year age group (P < 0.05).
    • No significant differences in genotype distribution were found between males and females.

    Conclusions:

    • The dominant HCV genotypes in Australia are 1 and 3, with a notable prevalence of subtype 3a.
    • The higher prevalence of genotype 1b in transfusion-acquired cases suggests potential differences in transmission routes.
    • The relatively high prevalence of genotype 3a in Australia is unusual compared to other developed countries, warranting further investigation.